Mark David Thomas is a San Francisco, California based nurse practitioner who is specialized as Pediatrics nurse. His current practice location is 1534 Clay St Apt 5, San Francisco. Patients can reach him at 918-557-0039. Mark David Thomas is RN, MS, PNP with specialization in Pediatrics and his NPI number (Unique professional ID assigned by NPPES) is 1740697937. Mark David Thomas specializes in caring for newborns, infants, toddlers, adolescents and young adults. He perform pediatric health care maintenance, including well child exams, developmental screenings and in-depth physical assessments, such as vision, hearing and dental. Pediatrics Nurse Practitioner (PNP) focus on well-child care and the prevention or management of common pediatric acute illnesses and chronic conditions.
Complete Profile:
Mark David Thomas speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
Name:
Mark David Thomas
Specialization:
Pediatrics Nurse Practitioner (PNP)
Gender:
Male
Credentials:
RN, MS, PNP
Practice Address:
1534 Clay St Apt 5, San Francisco, California, 94109-3848
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1740697937
NPI Enumeration Date:
19 Jul, 2014
NPI Last Update On:
19 Jul, 2014
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Mark David Thomas 1534 Clay St Apt 5, San Francisco, California
Zip:
94109-3848
Phone Number:
918-557-0039
Patients can reach Mark David Thomas at 1534 Clay St Apt 5, San Francisco, California or can call to book an appointment on 918-557-0039.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 September, 2024.